REINHARDT MAX 4

What Happened Max Reinhardt, President, Global Spine at Orthofix Medical (OFIX), sold a total of 2,133 shares in two open-market/private transactions to satisfy tax-withholding on restricted stock units (sell-to-cover). On 2026-03-04 he sold 1,080 shares at a weighted average price of $12.92 for approximately $13,950; on 2026-03-05 he sold 1,053 shares at a weighted average price of $12.55 for approximately $13,216. Combined proceeds were about $27,166 (overall weighted avg ≈ $12.74/share).

Key Details

• Transaction dates: 2026-03-04 (1,080 shares @ weighted avg $12.92, price range $12.80–$13.03) and 2026-03-05 (1,053 shares @ weighted avg $12.55, price range $12.48–$12.72). (See footnotes F2, F4.)
• Reason: Sell-to-cover to satisfy tax withholding in connection with RSU settlement; sales were pre-authorized and made without the reporting person's discretion (footnote F1).
• Holdings after transaction: filing notes inclusion of 19,417 previously reported restricted stock units (footnote F3). The filing did not disclose a complete post-transaction beneficial ownership total in the materials provided here.
• Filing: Report filed on 2026-03-06 for transactions on 2026-03-04 and 2026-03-05; appears to be timely.

Context

• These sales were tax-withholding (sell-to-cover) related to RSU settlement, which is a routine administrative transaction (code S/F for sale/tax withholding) and not the same signal as an unsolicited open-market sale for liquidity or portfolio reasons.
• No options were exercised and no discretionary trading plan (e.g., 10b5-1) is indicated in the provided notes; the filing states the sale was mandated by the compensation committee’s pre-existing sell-to-cover requirement.